Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 19 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Interventional 54 Observational 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1

Interventions

Blood Specimen Collection 31 Sorafenib 29 Nivolumab 29 Bevacizumab 26 Data Collection 24 Observation 23 palbociclib 22 Sunitinib 22 radium Ra 223 dichloride 20 enzalutamide 18 Rituximab 18 Ipilimumab 16 regorafenib 15 Drug Therapy 15 Trastuzumab 14 Docetaxel 14 ribociclib 12 exemestane 12 atezolizumab 12 Standard of Care 12 darolutamide 11 apalutamide 11 Leuprolide 11 Capecitabine 11 Afatinib 11 Bortezomib 10 Anastrozole 10 trastuzumab deruxtecan 9 pembrolizumab 9 avelumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × Tamoxifen × Clear all

NCT02753686 2023-02-15

Treat ER+ight

Novartis

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡